Cita APA (7a ed.)

Li, X., Fang, T., Xu, S., Jin, P., Zhou, D., Wang, Z., . . . Gao, Q. (2021). PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Li, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Li, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.